Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.
Pimozide Tablet Market aims to provide a comprehensive presentation of the global market for Pimozide Tablet, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pimozide Tablet. Pimozide Tablet Market contains market size and forecasts of Pimozide Tablet in global, including the following market information:
Global Pimozide Tablet Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Pimozide Tablet Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Pimozide Tablet companies in 2022 (%)
The global Pimozide Tablet market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
- The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
- 1Mg Segment to Reach $ Million by 2029, with a % CAGR in next six years.
- The global key manufacturers of Pimozide Tablet include Teva, Par Pharmaceutical, Johnson & Johnson, Eumedica, Pharmascience, Domina Pharmaceuticals and Aa Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
- We surveyed the Pimozide Tablet manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pimozide Tablet Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Pimozide Tablet Market Segment Percentages, by Type, 2022 (%)
Global Pimozide Tablet Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Pimozide Tablet Market Segment Percentages, by Application, 2022 (%)
- Hospitals
- Drugstores
- Others
Global Pimozide Tablet Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Pimozide Tablet Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Pimozide Tablet revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Pimozide Tablet revenues share in global market, 2022 (%)
- Key companies Pimozide Tablet sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Pimozide Tablet sales share in global market, 2022 (%)
key players include:
- Teva
- Par Pharmaceutical
- Johnson & Johnson
- Eumedica
- Pharmascience
- Domina Pharmaceuticals
- Aa Pharma
Outline of Major Chapters:
- Chapter 1: Introduces the definition of Pimozide Tablet, market overview.
- Chapter 2: Global Pimozide Tablet market size in revenue and volume.
- Chapter 3: Detailed analysis of Pimozide Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Pimozide Tablet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: Global Pimozide Tablet capacity by region & country.
- Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
- Chapter 11: The main points and conclusions of the report.
Industry Market Size
